Home

Gentamicin

Gentamicin is an aminoglycoside antibiotic used to treat serious infections caused by certain Gram-negative bacteria and, in combination with other agents, some Gram-positive infections. It is effective against organisms such as Pseudomonas aeruginosa and Enterobacteriaceae and is often employed for severe systemic infections, including septicemia, complicated urinary tract infections, and intra-abdominal infections, typically in conjunction with beta-lactam antibiotics to broaden coverage and enhance bactericidal activity.

Mechanism of action and pharmacodynamics: Gentamicin binds irreversibly to the 30S ribosomal subunit, causing misreading of

Pharmacokinetics and administration: The drug is usually given by parenteral routes (intravenous or intramuscular) because oral

Adverse effects and cautions: The most serious risks are nephrotoxicity and ototoxicity (affecting cochlear and vestibular

Resistance and history: Resistance mechanisms include aminoglycoside-modifying enzymes, altered ribosomal targets, and reduced uptake. Gentamicin was

messenger
RNA
and
disruption
of
protein
synthesis.
The
resulting
bactericidal
effect
is
concentration-dependent,
and
a
post-antibiotic
effect
may
persist
after
drug
levels
fall,
allowing
once-daily
or
extended-interval
dosing
in
some
settings.
absorption
is
poor.
It
distributes
mainly
in
extracellular
fluid
and
is
excreted
largely
unchanged
by
the
kidneys.
Dosing
and
duration
are
influenced
by
renal
function,
and
monitoring
of
drug
levels
and
kidney
function
is
common
to
minimize
toxicity.
function).
Less
common
effects
include
neuromuscular
blockade
and
hypersensitivity.
Risk
is
higher
with
elevated
trough
levels,
prolonged
therapy,
dehydration,
existing
kidney
disease,
advanced
age,
and
concurrent
nephrotoxic
or
ototoxic
drugs
(for
example,
loop
diuretics).
Use
requires
careful
monitoring,
especially
in
renal
impairment
and
during
pregnancy
or
lactation.
developed
in
the
mid-20th
century
and
has
since
become
a
staple
in
the
management
of
serious
Gram-negative
infections,
often
as
part
of
combination
therapy.